Victory Capital Management
FLNA

Victory Capital Management’s Filana Therapeutics FLNA Stock Holding History

Victory Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,733
Closed -$274K – 2765
2022
Q2 		$274K Sell
9,733
-4,395
-31% -$111K ﹤0.01% 2265
2022
Q1 		$295K Buy
14,128
+1,938
+16% +$82.1K ﹤0.01% 2304
2021
Q4 		$533K Sell
12,190
-836
-6% -$43.8K ﹤0.01% 2115
2021
Q3 		$809K Buy
13,026
+1,982
+18% +$165K ﹤0.01% 1946
2021
Q2 		$944K Buy
11,044
+5,211
+89% +$279K ﹤0.01% 1916
2021
Q1 		$262K Buy
+5,833
New +$229K ﹤0.01% 2449
2020
Q2 		– Sell
-7,338
Closed -$30K – 3146
2020
Q1 		$30K Buy
+7,338
New +$48.6K ﹤0.01% 2959
2019
Q4 		– Sell
-2,665
Closed -$3K – 3163
2019
Q3 		$3K Buy
+2,665
New +$3.42K ﹤0.01% 3576

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management's FLNA Position: Q3 2022 in Review

Victory Capital Management sold out of Filana Therapeutics (FLNA) in Q3 2022, closing a stake of 9,733 shares — an estimated $274K sold.

Victory Capital Management first reported a position in FLNA in Q3 2019 and held it in 8 quarters. The position peaked at $944K in Q2 2021. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

  • Victory Capital Management reported no remaining Filana Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 9,733 Filana Therapeutics shares in Q3 2022, an estimated $274K.
  • Victory Capital Management first reported a position in Filana Therapeutics in Q3 2019 and held it in 8 quarters.
  • Victory Capital Management's Filana Therapeutics position peaked at $944K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.